|
|
Drugs for Uterine Corpus Endometrial Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 117)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Paclitaxel | approved, vet_approved | Phase 3, Phase 2, Phase 1 | 2864 | 33069-62-4 | 36314 | (2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 157069-30-2 33069-62-4 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv. 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv. 7-Epi-Paclitaxel 7-Epi-Taxol 7-Epipaclitaxel 7-Epitaxol 7-epi-Paclitaxel 7-epi-Taxol AB00513812 ABI 007 ABI-007 ABI007 AC-675 AC1L1IOG AC1L1VJI AC1L9AVF ACon1_002231 ANX-513 Abraxane Abraxane (TN) Abraxane I.V. Suspension Abraxis BioScience brand of albumin-bound paclitaxel Ambotz33069-62-4 Anzatax Asotax BIDD:PXR0046 BMS 181339-01 BMS-181339 BMS-181339-01 BPBio1_000320 BRD-A23723433-001-01-2 BRD-A28746609-001-04-0 BRD-K62008436-001-03-1 BSPBio_000290 BSPBio_001152 BSPBio_002614 Bio-0076 Bio1_000362 Bio1_000851 Bio1_001340 Bio2_000416 Bio2_000896 Bristaxol C07394 C466458 C47H51NO14 CCRIS 8143 CHEBI:103439 CHEBI:45863 CHEMBL100910 CHEMBL418410 CHEMBL48 CID36314 CID441276 CID4666 CID6713921 CID6915727 CPD-8718 Capxol D00491 DB01229 DHP-107 DHP-208 DRG-0190 DTS-301 DivK1c_000441 EU-0101201 Ebetaxel EmPAC Epitaxol Genaxol Genetaxyl Genexol Genexol-PM HMS1362J13 HMS1568O12 HMS1792J13 HMS1922K08 HMS1990J13 HMS2090D07 HMS2093K15 HMS501G03 HSDB 6839 I06-0014 IDI1_000441 IDI1_002171 Intaxel KBio1_000441 KBio2_000492 KBio2_002016 KBio2_002509 KBio2_003060 KBio2_004584 KBio2_005077 KBio2_005628 KBio2_007152 KBio2_007645 KBio3_000903 KBio3_000904 KBio3_001834 KBio3_002987 KBioGR_000492 KBioGR_001893 | KBioGR_002509 KBioSS_000492 KBioSS_002016 KBioSS_002517 LMPR0104390001 LS-31070 LipoPac Lopac0_001201 MBT 0206 MEGxp0_001940 MLS000863266 MLS001077297 MLS002154218 MLS002172439 MLS002695976 MPI-5018 Micellar Paclitaxel Mitotax MolPort-001-742-627 MolPort-003-665-783 MolPort-003-932-365 NCGC00024995-02 NCGC00024995-03 NCGC00024995-04 NCGC00024995-05 NCGC00024995-06 NCGC00024995-07 NCGC00164367-01 NCGC00164367-02 NCGC00164367-03 NCI60_000601 NINDS_000441 NK 105 NP-010981 NSC 125973 NSC-125973 NSC125973 NSC358882 Nanotaxel Neuro_000060 Nova-12005 OAS-PAC-100 OncoGel Onxal Onxol Onxol, Taxol, Nov-Onxol, Paclitaxel P1632 Paclical Pacligel Paclitaxel Paclitaxel (JAN/USP) Paclitaxel (JAN/USP/INN) Paclitaxel (Taxol) Paclitaxel [USAN:INN:BAN] Paxceed Paxene Paxoral Plaxicel Praxel Prestwick0_000155 Prestwick1_000155 Prestwick2_000155 Prestwick3_000155 Probes2_000350 QW 8184 S-8184 Paclitaxel Injectable Emulsion S1150_Selleck SDCCGMLS-0066823.P001 SDP-013 SMP1_000228 SMR000394086 SMR000857385 SPBio_000943 SPBio_002229 SPECTRUM1503908 ST50306996 Spectrum2_000872 Spectrum3_001057 Spectrum4_001197 Spectrum5_001491 Spectrum_001536 T 7402 T1912_SIGMA T7191_SIGMA T7402_SIGMA TA1 TAXOL (TN) TAXOL, 10-EPI, TXL TaxAlbin Taxol Taxol A Taxol Konzentrat Taxol.RTM. (Registered Trademark) UNII-P88XT4IS4D UPCMLD-DP108:001 UPCMLD-DP108:002 Vascular Wrap Xorane Yewtaxan abi-007 albumin-bound paclitaxel cMAP_000068 nab-paclitaxel nchembio.188-comp1 nchembio.2007.34-comp9 nchembio.215-comp9 nchembio853-comp6 paclitaxel weekly paclitaxel |
| | 2 | | Ifosfamide | approved | Phase 3 | 400 | 3778-73-2 | 3690 | (+-)-Ifosfamid (+-)-Ifosphamide (+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide (D,L)-Ifosfamide (R,S)-Ifosphamide (R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd 2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI) 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 3,} 2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 36341-88-5 3778-73-2 84711-20-6 A 4942 AB00513932 AC-2113 AC1L1GHW ASTA Z 4942 Ambap3778-73-2 Asta Z 4942 BPBio1_000865 BRN 0611835 BSPBio_000785 C07047 CAS-3778-73-2 CCRIS 352 CHEBI:5864 CHEMBL1024 CID3690 Cyfos D00343 D007069 DB01181 EINECS 223-237-3 HMS1570H07 HMS2090M12 HMS2093N07 HSDB 7023 Holoxan Holoxan 1000 I-Phosphamide I06-0494 IFEX (TN) Ifex Ifosfamid Ifosfamida Ifosfamida [INN-Spanish] Ifosfamide (JAN/USP/INN) | Ifosfamide Sterile Ifosfamide [USAN:INN:BAN:JAN] Ifosfamidum Ifosfamidum [INN-Latin] Ifosphamide Ifsofamide Iphosphamid Iphosphamid(e) Iphosphamide Iso Endoxan Iso-Endoxan Isoendoxan Isofosfamide Isophosphamide Isosfamide LS-102 LS-99799 MJF 9325 MJF-9325 MLS002154021 Mitoxana Mitoxana, Ifex, Ifosfamide MolPort-003-666-704 N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German] N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine NCGC00016639-01 NCGC00179435-01 NCI-C01638 NCI60_000233 NPFAPI-04 NSC 109,724 NSC 109724 NSC-109,724 NSC-109724 NSC109,724 NSC109724 Naxamide Prestwick0_000833 Prestwick1_000833 Prestwick2_000833 Prestwick3_000833 S1302_Selleck SMR001233348 SPBio_002706 STL058690 UNII-UM20QQM95Y WLN: T6NPOTJ AM2G BO B2G Z 4942 Z-4942 Z4942 ifosfamide isosfamide {3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1, | |
| | 3 | | Carboplatin | approved | Phase 3, Phase 2 | 2050 | 41575-94-4 | 10339178, 498142, 38904 | (SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum /h1-3H2,(H,7,8)(H,9,10) /q 1,1-Cyclobutanedicarboxylate diammine platinum (II) 1,1-Cyclobutanedicarboxylate diammine platinum(II) 2*-1 2*1H2 41575-94-4 70903-55-8 AC-1457 AC1L8I6U Ambap41575-94-4 BSPBio_003145 C 2538 C2043 C2538_SIGMA C6H10N2O4Pt CBDCA CCRIS 3404 CHEBI:31355 CHEMBL1351 CHEMBL288376 CID10339178 CID2567 CID38904 CID426756 CID498142 CID5352133 CID6398587 CID6603770 Carbopaltin Carboplatin Carboplatin (JAN/USP/INN) Carboplatin (USAN) Carboplatin [USAN:INN:BAN:JAN] Carboplatine Carboplatine [French] Carboplatino Carboplatino [Spanish] Carboplatinum Carboplatinum [Latin] Cbdca Cyclobutane-1,1-dicarboxylate D01363 DB00958 Diammine(1,1-cyclobutanedicarboxylato)platinum (II) Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum Diammine-1,1-cyclobutane dicarboxylate platinum II DivK1c_000892 EINECS 255-446-0 EU-0100230 Ercar HMS1921J16 HMS2090M05 HMS2092B22 HMS502M14 HSDB 6957 I14-2390 IDI1_000892 IUPAC: Azane InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6 | JM 8 JM-8 KBio1_000892 KBio2_002009 KBio2_004577 KBio2_007145 KBio3_002645 KBioGR_000713 KBioSS_002009 LS-117689 Lopac-C-2538 Lopac0_000230 MolPort-003-665-501 MolPort-003-845-609 NCGC00015223-01 NCGC00093695-01 NCGC00094961-01 NCGC00094961-02 NCGC00094961-03 NCGC00162099-01 NCGC00162099-02 NCGC00167800-01 NCGC00178242-01 NINDS_000892 NSC 201345 NSC 241240 NSC-241240 NSC201345 NSC241240 Paraplatin Paraplatin (TN) Paraplatin, Carboplatin Paraplatin-AQ Platinum(+2) Cation Platinum(II), (1, 1-cyclobutanedicar Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2) Platinum, {diammine[1,1-cyclobut S1215_Selleck SPBio_000716 SPECTRUM1502106 Spectrum2_000898 Spectrum3_001503 Spectrum4_000337 Spectrum5_001094 Spectrum_001529 UNII-BG3F62OND5 azanide carboplatin cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II) cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii) cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II) cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II) cis-Diammine(1,1-cyclobutanedicarboxylato) platinum cis-Diammine(1,1-cyclobutanedicarboxylato)platinum cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II) cis-Diammine(cyclobutanedicarboxylato)platinum II cyclobutane-1,1-dicarboxylic acid diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum nchembio.573-comp10 nchembio773-comp2 nchembio873-comp3 platinum(2+) |
| | 4 | | Mechlorethamine | approved | Phase 3 | 397 | 51-75-2 | 4033 | .Beta.,.beta.'-Dichlorodiethyl-N-methylamine 1, 5-Dichloro-3-methyl-3-azapentane hydrochloride 126-85-2 (N-oxide) 2,2'-Dichloro-N-me 2,2'-Dichloro-N-methyldiethylamine 2,2'-Dichlorodiethyl-methylamine 2,2'-dichloro-N-methyldiethylamine 2-Chloro-N-(2-chloroethyl)-N-methylethanamine 302-70-5 (N-oxide, hydrochloride) 51-75-2 55-86-7 (HYDROCHLORIDE) AC1L1H9H Antimit BRN 0605323 BSPBio_001947 Bis(2-chloroethyl)methylamine Bis(beta-chloroethyl) methylamine Bis(beta-chloroethyl)methylamine C07115 C5H11Cl2N CCRIS 447 CHEBI:28925 CHEMBL427 CID4033 Carolysine Caryolysin Caryolysine Chloramine (the nitrogen mustard) Chlorethazine Chlormethine Chlormethine (INN) Chlormethine [INN:BAN] Chlormethinum [INN-Latin] Cloramin Clormetina Clormetina [INN-Spanish] D07671 DB00888 Di(2-chloroethyl)methylamine Dichlor amine Dichloren DivK1c_000759 EINECS 200-120-5 ENT-25294 Embechine Embichin HMS1920J15 HMS2091B04 HMS502F21 HN-2 HN2 HSDB 5083 I14-8708 IBS-L0033631 IDI1_000759 KBio1_000759 KBio2_001369 KBio2_003937 KBio2_006505 KBio3_001447 | KBioGR_001448 KBioSS_001369 LS-7559 MBA Me chloroethamine Mebichloramine Mechlorethamine Mechlorethanamine Mechloroethamine Mecloretamina Mecloretamina [Italian] Methylbis(2-chloroethyl)amine Methylbis(beta-chloroethyl)amine Methyldi(2-chloroethyl)amine Mitoxine (*Hydrochloride*) MolPort-001-785-592 Mustargen Mustine Mustine note Mutagen N,N-Bis(2-chloroethyl)-N-methylamine N,N-Bis(2-chloroethyl)methylamine N,N-Di(chloroethyl)methylamine N-Lost N-Methyl lost N-Methyl-2,2'-dichlorodiethylamine N-Methyl-bis(2-chloroethyl)amine N-Methyl-bis(beta-chloroethyl)amine N-Methyl-bis-chloraethylamin N-Methyl-bis-chloraethylamin [German] N-Methyl-lost N-Methyl-lost [German] N-methyl-bis(2-chloroethyl)amine NCGC00091835-02 NCGC00091835-03 NCGC00091835-04 NCGC00091835-05 NCI60_041682 NINDS_000759 NSC762 Nitol (*Hydrochloride*) Nitrogen mustard Nitrogen mustard (HN-2) Nitrogranulogen SPBio_000496 SPECTRUM1500375 Spectrum2_000448 Spectrum3_000484 Spectrum4_000924 Spectrum5_001702 Spectrum_000889 Stickstofflost (*Hydrochloride*) Stickstofflost (ebewe) T 1024 T-1024 TL 146 UNII-50D9XSG0VR beta,Beta'-dichlorodiethyl-N-methylamine beta,beta'-Dichlorodiethyl-N-methylamine mechlorethamine thyldiethylamine β,β'-dichlorodiethyl-N-methylamine |
| | 5 | | Cisplatin | approved | Phase 3, Phase 2, Phase 1 | 2770 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 6 | | Doxorubicin | approved, investigational | Phase 3, Phase 2, Phase 1 | 1751 | 23214-92-8 | 31703 | (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione 111266-55-8 14-Hydroxydaunomycin 14-Hydroxydaunorubicine 14-hydroxydaunomycin 14-hydroxydaunorubicine 23214-92-8 23257-17-2 24385-08-8 25311-50-6 25316-40-9 25316-40-9 (hydrochloride) 29042-30-6 AC1L1M5T AC1Q29OJ ADM ADR Adriablastin Adriacin (hydrochloride salt) Adriamycin Adriamycin PFS Adriamycin PFS (hydrochloride salt) Adriamycin RDF Adriamycin RDF (hydrochloride salt) Adriamycin Semiquinone Adriamycin semiquinone Adriblas tina Adriblastin Adriblastina Adriblastina (TN) Adriblastina (hydrochloride salt) Aerosolized Doxorubicin BPBio1_000502 BRD-K92093830-003-04-3 BSPBio_000456 BSPBio_001031 C01661 C27H29NO11 CCRIS 739 CHEBI:28748 CHEMBL179 CID31703 Caelyx Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74 Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120 D03899 DB00997 DM2 DOX-SL Doxil Doxo Doxorubicin Doxorubicin (USAN/INN) Doxorubicin HCl | Doxorubicin Hydrochloride Doxorubicin [USAN:INN:BAN] Doxorubicin citrate Doxorubicin hydrochloride (hydrochloride salt) Doxorubicin-P4/D10 Doxorubicin-P4/D10 conjugate Doxorubicin-hLL1 Doxorubicin-hLL1 conjugate Doxorubicina Doxorubicina [INN-Spanish] Doxorubicine Doxorubicine [INN-French] Doxorubicinum Doxorubicinum [INN-Latin] EINECS 245-495-6 FI 106 Farmablastina (hydrochloride salt) HMS2089H06 HSDB 3070 Hydroxydaunomycin hydrochlor ide (hydrochloride salt) Hydroxydaunomycin hydrochloride (hydrochloride salt) Hydroxydaunorubicin Hydroxydaunorubicin hydrochloride (hydrochloride salt) JT9100000 LMPK13050001 LS-1029 LS-165655 MLS000759533 Myocet NCI-C01514 NChemBio.2007.10-comp13 NDC 38242-874 NIOSH/JT9100000 NSC 123127 Prestwick0_000438 Prestwick1_000438 Prestwick2_000438 Prestwick3_000438 Probes1_000151 Probes2_000129 RDF Rubex Resmycin Rubex Rubex (hydrochloride salt) SMP1_000106 SPBio_002395 TLC D-99 ThermoDox Triferric doxorubicin UNII-80168379AG adiblastine (hydrochloride salt) adr iablatina (hydrochloride salt) adriablastine (hydrochloride salt) adriablatina (hydrochloride salt) adriblatina (hydrochloride salt) doxorubicin nchembio809-comp5 |
| | 7 | | Lenograstim | approved | Phase 3, Phase 1 | 1220 | 135968-09-1 | | G-CSF (CHO cell derived) Glycosylated recombinant G-CSF Glycosylated recombinant granulocyte colony stimulating factor | Granulocyte colony stimulating factor 3 (CHO cell derived) Granulocyte colony-stimulating factor lenograstim Lenograstim (genetical recombination) Lenograstim rDNA | |
| | 8 | | Succinylcholine | approved | Phase 3, Phase 2, Phase 1 | 169 | 306-40-1 | 5314 | 2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM) 2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium) 2ha2 2ha6 306-40-1 4-04-00-01451 (Beilstein Handbook Reference) 541-19-5 (diiodide) 55-94-7 (dibromide) 71-27-2 (dichloride) AC1L1K2T Anectine BRN 1805311 C07546 C14H30N2O4 CHEBI:45652 CHEMBL703 CID5314 Choline, succinate (2:1) (ester) Choline, succinate (ester) DB00202 Diacetylcholine Dicholine succinate Ditilin Ditiline HMS2090P14 HSDB 3254 InChI=1/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2 L000926 LS-53328 Listenon | Lopac-S-8251 Lopac0_001080 Lysthenon MolPort-002-964-486 NCGC00015971-01 NCGC00015971-03 NCGC00162336-01 Quelicin Quelicin Preservative Free SCK ST50437287 STK177290 Scoline Succicuran Succinic acid, diester with choline Succinic acid, diester with choline chloride Succinocholine Succinoylcholine Succinyl choline Succinylbischoline Succinylcholine Succinylcholine Chloride Succinyldicholine Sucostrin Suxamethonium Suxamethonium chloride UNII-J2R869A8YF ZINC01530820 succinylcholine succinyldicholine trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium |
| | 9 | | Metformin | approved | Phase 2, Phase 3 | 1803 | 657-24-9 | 14219, 4091 | 1,1-Dimethyl biguanide 1,1-Dimethylbiguanide 3-(diaminomethylidene)-1,1-dimethylguanidine 657-24-9 AC1L1HE4 AKOS000121065 Apo-Metformin BIDD:GT0697 BPBio1_000009 BRD-K79602928-003-04-1 BSPBio_000007 BSPBio_002314 C07151 C4H11N5 CAS-1115-70-4 CCRIS 9321 CHEBI:6801 CHEMBL1431 CID4091 D04966 DB00331 DMGG Diabetosan Diabex Dimethylbiguanid Dimethylbiguanide Dimethylbiguanidine Dimethyldiguanide Dimethylguanylguanidine EINECS 211-517-8 Fluamine Flumamine Fortamet Gen-Metformin Glifage Gliguanid Glucophage Glucophage XR Glumetza Glycon HMS2089D19 HSCI1_000295 Haurymelin Haurymellin Islotin KBio2_002310 KBio2_004878 KBio2_007446 KBio3_002790 KBioGR_002310 | KBioSS_002312 LA-6023 LS-43899 Melbin Metformin Metformin (USAN/INN) Metformin HCL Metformin [USAN:INN:BAN] Metformina Metformina [DCIT] Metformina [Spanish] Metformine Metformine [INN-French] Metformine pamoate Metforminum Metforminum [INN-Latin] Metiguanide MolPort-002-929-560 MolPort-004-288-389 MolPort-005-767-418 Mylan-Metformin N,N-Dimethylbiguanide N,N-Dimethyldiguanide N,N-Dimethylimidodicarbonimidic diamide N,N-dimethylimidodicarbonimidic diamide N1,N1-Dimethylbiguanide NCGC00016564-01 NCGC00016564-02 NCGC00016564-03 NNDG Novo-Metformin Nu-Metformin PMS-Metformin Prestwick0_000004 Prestwick1_000004 Prestwick2_000004 Prestwick3_000004 Ran-Metformin Ratio-Metformin Riomet S2483_Selleck SPBio_001928 STK011633 Sandoz Metformin Siofor T5895664 Teva-Metformin UNII-9100L32L2N ZINC12859773 cMAP_000016 metformin metformin hydrochloride |
| | 10 | | Menthol | approved | Phase 3 | 2606 | 2216-51-5 | 16666 | (− ()-Menthol (+)-Neo-menthol (+)-p-Menthan-3-ol (+-)-(1R*,3R*,4S*)-Menthol (+-)-Menthol (+/-)-Menthol (+/-)-p-Menthan-3-ol (-)-(1R,3R,4S)-Menthol (-)-Menthyl alcohol (-)-menthol (-)-p-Menthan-3-ol (-)-trans-p-Menthan-cis-ol (1R)-(-)-Menthol (1R,2S,5R)-(-)-menthol (1R,2S,5R)-Menthol (1R,3R,4S)-(-)-MENTHOL (1R,3R,4S)-(-)-Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol (1S, 2S, 5R)-(+)-Neomenthol (1S,2R,5R)-(+)-Isomenthol (1S,2R,5S)-(+)-Menthol (1S,2R,5S)-Menthol (1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol (1r,2s,5r)-(-)-menthol (L)-MENTHOL (R)-(-)-Menthol (r)-(-)-menthol )-Menthol --MENTHOL 1-Menthol 1490-04-6 15356-60-2 15356-70-4 15785_RIEDEL 15785_SIAL 19863P 2-Isopropyl-5-methylcyclohexanol 20747-49-3 2216-51-5 3-p-Menthol 4-Isopropyl-1-methylcyclohexan-3-ol 491-02-1 5-Methyl-2-(1-methylethyl)-cyclohexanol 5-Methyl-2-(1-methylethyl)cyclohexanol 5-methyl-2-(propan-2-yl)cyclohexanol 5-methyl-2-propan-2-ylcyclohexan-1-ol 551376_ALDRICH 551376_FLUKA 588733_ALDRICH 613290_ALDRICH 613290_FLUKA 63660_FLUKA 63670_ALDRICH 63670_FLUKA 63975-60-0 6C6A4A8C-A054-468C-A1F0-F29E39838CF2 89-78-1 98167-53-4 AC1L1B2E AC1L28FR AC1Q1NQ2 AC1Q2QQM AI3-08161 AI3-52408 AKOS000119740 AR-1J3337 BB_NC-0057 BRN 1902288 BRN 3194263 BSPBio_003062 C00400 C10H20O CCRIS 3728 CCRIS 375 CCRIS 4666 CCRIS 9231 CHEBI:15409 CHEBI:545611 CHEMBL256087 CHEMBL470670 CID1254 CID16666 Caswell No. 540 D-(-)-Menthol D-p-Menthan-3-ol D00064 D008610 D04849 D04918 DB00825 DivK1c_000820 EINECS 201-939-0 EINECS 207-724-8 EINECS 216-074-4 EINECS 218-690-9 EINECS 239-387-8 EINECS 239-388-3 EPA Pesticide Chemical Code 051601 FEMA No. 2665 Fisherman's friend lozenges Fisherman's friend lozenges (TN) HMS1922G13 HMS2092L14 HMS502I22 | HSDB 5662 HSDB 593 Headache crystals Hexahydrothymol I06-1216 I14-7371 IDI1_000820 KBio1_000820 KBio2_000785 KBio2_003353 KBio2_005921 KBio3_002562 KBioSS_000785 L-(-)-Menthol L-(-)-menthol L-Menthol L-menthol LMPR0102090001 LS-2353 LS-57201 LS-886 LS-89531 LS-89533 Levomenthol Levomenthol [INN:BAN] Levomentholum Levomentholum [INN-Latin] Levomentol M0321 M0545 M2772_SIAL MENTHOL MLS002207256 Menthacamphor Menthol Menthol (USP) Menthol (VAN) Menthol natural Menthol natural, brazilian Menthol racemic Menthol racemique Menthol racemique [French] Menthol solution Menthol, (1alpha,2beta,5alpha)-Isomer Menthomenthol Menthyl alcohol MolPort-000-849-729 MolPort-001-793-392 NCGC00159382-02 NCGC00159382-03 NCGC00164247-01 NCGC00164247-02 NCI-C50000 NINDS_000820 NOOLISFMXDJSKH-KXUCPTDWBX NSC 2603 NSC 62788 NSC2603 NSC62788 Neoisomenthol Peppermint camphor RACEMIC MENTHOL U.S.P. Racementhol Racementhol [INN:BAN] Racementholum Racementholum [INN-Latin] Racementol Racementol [INN-Spanish] Racemic menthol Robitussin Cough Drops SDCCGMLS-0066659.P001 SMR001306785 SPBio_000869 SPECTRUM1503134 STK802468 Spectrum2_000855 Spectrum3_001561 Spectrum5_001060 Spectrum_000305 Tra-kill tracheal mite killer U.S.P. Menthol U.S.p. Menthol UNII-BZ1R15MTK7 UNII-L7T10EIP3A UNII-YS08XHA860 W266507_ALDRICH W266523_ALDRICH W266590_ALDRICH WLN: L6TJ AY1&1 BQ D1 WLN: L6TJ AY1&1 DQ D1 -L ZINC01482164 cis-1 ,3-trans-1,4-(+-)-menthol cis-1,3-trans-1,4-(+-)-menthol d,l-Menthol d-Menthol d-Neomenthol dl-3-p-Menthanol dl-Menthol dl-Menthol (JP15) l-(-)-Menthol l-Menthol l-Menthol (JP15) l-Menthol (TN) l-Menthol (natural) nchembio862-comp1 p-Menthan-3-ol rac-Menthol |
| | 11 | | Doxil | Approved June 1999 | Phase 3, Phase 2, Phase 1 | 1751 | | 31703 | | Evacet LipoDox Pegylated Liposomal Doxorubicin Hydrochloride liposomal doxorubicin |
| | 12 | | Isophosphamide mustard | | Phase 3 | 400 | | | | 13 | | Antineoplastic Agents, Alkylating | | Phase 3 | 4603 | | | | 14 | | Antineoplastic Agents, Phytogenic | | Phase 3, Phase 2, Phase 1 | 5602 | | | | 15 | | Albumin-Bound Paclitaxel | | Phase 3, Phase 2, Phase 1 | 2864 | | | | 16 | | Alkylating Agents | | Phase 3 | 4827 | | | | 17 | | Antimitotic Agents | | Phase 3, Phase 2, Phase 1 | 5657 | | | | 18 | | Adjuvants, Immunologic | | Phase 3, Phase 1 | 2554 | | | | 19 | | Anti-Bacterial Agents | | Phase 3, Phase 2, Phase 1 | 11226 | | | | 20 | | Antibiotics, Antitubercular | | Phase 3, Phase 2, Phase 1 | 7180 | | | | 21 | | Topoisomerase Inhibitors | | Phase 3, Phase 2, Phase 1 | 5069 | | | | 22 | | Peripheral Nervous System Agents | | Phase 3, Phase 2, Phase 1 | 23689 | | | | 23 | | Neuromuscular Agents | | Phase 3, Phase 2, Phase 1 | 1180 | | | | 24 | | Neuromuscular Depolarizing Agents | | Phase 3, Phase 2, Phase 1 | 139 | | | | 25 | | Hypoglycemic Agents | | Phase 2, Phase 3 | 5896 | | | | 26 | | Neuromuscular Blocking Agents | | Phase 3, Phase 2, Phase 1 | 429 | | | | 27 | | Megestrol acetate | approved, vet_approved | Phase 2 | 68 | 595-33-5 | 11683 | 17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate 17alpha-Acetoxy-6-dehydro-6-methylprogesterone 17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate 17α-Acetoxy-6-dehydro-6-methylprogesterone 17α-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate 6-Dehydro-6-methyl-17alpha-acetoxyprogesterone 6-Dehydro-6-methyl-17α-acetoxyprogesterone 6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione | 6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate 6-Methyl-17α-acetoxypregna-4,6-diene-3,20-dione 6-Methyl-17α-hydroxy-delta(sup 6)-progesterone acetate 6-Methyl-6-dehydro-17alpha-acetoxyprogesterone 6-Methyl-6-dehydro-17α-acetoxyprogesterone 6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate 6-Methyl-delta(sup 4,6)-pregnadien-17α-ol-3,20-dione acetate 6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone 6-Methyl-delta(sup 6)-dehydro-17α-acetoxyprogesterone MGA Megace |
| | 28 | | Everolimus | approved | Phase 2 | 1940 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 29 | | Gemcitabine | approved | Phase 2, Phase 1 | 2018 | 95058-81-4 | 60750 | 103882-84-4 122111-03-9 2',2'-DiF-dC 2',2'-Difluoro-2'-deoxycytidine 2',2'-Difluorodeoxycytidine 2'-Deoxy-.beta.-D-2',2'-difluorocytidine 2'-Deoxy-2',2'-difluorocytidine 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one 4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 95058-81-4 AB1004842 AC1L1TUQ C07650 CCRIS 8984 CHEBI:175901 CHEMBL888 CID60750 Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine D02368 DB00441 DDFC DFDC DFdC DFdCyd Folfugem GEO Gamcitabine GemLip Gemcel | Gemcin Gemcitabin Gemcitabina Gemcitabina [INN-Spanish] Gemcitabine Gemcitabine (USAN/INN) Gemcitabine HCl Gemcitabine hydrochloride Gemcitabine stereoisomer Gemcitabinum Gemcitabinum [INN-Latin] Gemtro Gemzar Gemzar (hydrochloride) HMS2089P10 HSDB 7567 Inno-D07001 LS-59139 LY 188011 LY-188011 LY188011 NCGC00168784-01 NChemBio.2007.10-comp25 NSC 613327 NSC613327 TL8005979 UNII-B76N6SBZ8R ZINC18279854 Zefei gemcitabine nchembio.573-comp7 nchembio.90-comp2 | |
| | 30 | | Nintedanib | approved | Phase 2 | 116 | 656247-17-5 | 56843413 | | Vargatef methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate nintedanib | |
| | 31 | | Medroxyprogesterone acetate | approved, investigational | Phase 2 | 148 | 71-58-9 | | (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione 17-Acetoxy-6alpha-methylprogesterone 17-Acetoxy-6α-methylprogesterone 17alpha-Hydroxy-6alpha-methylprogesterone acetate 17α-hydroxy-6α-methylprogesterone acetate 6-alpha-Methyl-17-alpha-acetoxyprogesterone 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate 6alpha-Methyl-17-acetoxy progesterone | 6alpha-Methyl-17alpha-hydroxyprogesterone acetate 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate 6α-Methyl-17-acetoxy progesterone 6α-Methyl-17α-hydroxyprogesterone acetate MPA Medroxyacetate progesterone Medroxyprogesterone 17-acetate Medroxyprogesterone acetate Methylacetoxyprogesterone Metigestrona |
| | 32 | | Tamoxifen | approved | Phase 2 | 390 | 10540-29-1 | 2733526 | (Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine (Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine (Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC) (Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine ,citrate 1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene 1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene 1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene 1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene 1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene 10540-29-1 1ya4 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 54965-24-1 (citrate) AC1MBZ3R Apo-Tamox Apo-tamox BIDD:ER0008 BIDD:GT0009 BIDD:PXR0003 BPBio1_000278 BRD-K93754473-001-02-9 BRD-K93754473-048-05-3 BSPBio_000252 BSPBio_001150 BSPBio_001982 C07108 C26H29NO CCRIS 3275 CHEBI:41774 CHEMBL83 CID2733526 Citofen Crisafeno D08559 DB00675 Diemon EINECS 234-118-0 Gen-Tamoxifen Gen-tamoxifen HMS1362J11 HMS1792J11 HMS1990J11 HMS2090N08 HSDB 6782 ICI 47699 ICI-46,474 ICI-47699 IDI1_000258 IDI1_002170 Istubol Kessar L024126 LS-393 Lopac0_001203 MLS001332535 MLS001332536 MolPort-003-850-384 | NCGC00024928-01 NCGC00024928-03 NCGC00024928-04 NCGC00024928-05 NCGC00024928-07 NCGC00024928-08 NCGC00024928-09 NCGC00024928-12 NSC727681 Noltam Nolvadex Nolvadex-D Nourytam Novaldex Novo-Tamoxifen Oncomox PMS-Tamoxifen Pms-Tamoxifen Prestwick2_000146 Prestwick3_000146 QTL1_000079 Retaxim SMR000059172 ST50511785 Spectrum5_001417 Spectrum5_002043 T5648_SIGMA TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1)) TRANS FORM OF TAMOXIFEN Tamizam Tamofen Tamone Tamoplex (TN) Tamoxasta Tamoxen Tamoxifen Tamoxifen (INN) Tamoxifen (TN) Tamoxifen (Z) Tamoxifen Citrate Tamoxifen [INN:BAN] Tamoxifen and its salts Tamoxifene Tamoxifene [INN-French] Tamoxifeno Tamoxifeno [INN-Spanish] Tamoxifenum Tamoxifenum [INN-Latin] Tamoxifène Tocris-0999 Tomaxithen Trans-Tamoxifen UNII-094ZI81Y45 UPCMLD-DP027 Valodex Zemide cMAP_000044 nchembio.140-comp7 nchembio.76-comp1 nchembio732-comp3 tamoxifen trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine trans-Tamoxifen | |
| | 33 | | Sirolimus | approved, investigational | Phase 2 | 1940 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 34 | | Miconazole | approved, investigational, vet_approved | Phase 2 | 3706 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 35 | | Gefitinib | approved, investigational | Phase 2 | 361 | 184475-35-2 | 123631 | 184475-35-2 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline 4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine AC-1556 AC1L3X0A AKOS000280752 BCB03_000781 Bio-0046 C419708 CCRIS 9011 CHEBI:49668 CHEMBL939 CID123631 CU-00000000396-1 D01977 DB00317 DB07998 EC-000.2409 EN002708 FT-0081035 Gefitini Gefitinib Gefitinib (JAN/USAN/INN) Gefitinib [USAN] Gefitinib, Iressa, ZD1839 Gelfitinib HMS2089B19 I01-1227 | IRE Iressa Iressa (TN) Iressa(TM) Irressat K00240 KBioSS_002241 Kinome_3321 Kinome_3322 LS-139916 MolPort-000-883-335 N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine NCGC00159455-02 NCGC00159455-03 NSC715055 S1025_Selleck STK621310 UNII-S65743JHBS ZD 1839 ZD-1839 ZD-1839, Iressa, Gefitinib ZD1839 ZINC19632614 gefitinib nchembio.117-comp18 nchembio866-comp14 |
| | 36 | | Doxycycline | approved, investigational, vet_approved | Phase 2 | 243 | 564-25-0 | 54671203 | (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide 10597-92-9 17086-28-1 (mono-hydrate) 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS) 24390-14-5 41411-66-9 (6-epimer, mono-hydrochloride) 5-Hydroxy-alpha-6-deoxytetracycline 5-hydroxy-α-6-deoxytetracycline 564-25-0 6-Deoxyoxytetracycline 6-Deoxytetracycline 6-alpha-Deoxy-5-oxytetracycline 6-alpha-deoxy-5-oxytetracycline 69935-17-7 (mono-hydrochloride, di-hydrate) 6alpha-Deoxy-5-oxytetracycline 6alpha-deoxy-5-oxytetracycline 6α-deoxy-5-oxytetracycline 7164-70-7 7264-10-0 94088-85-4 (calcium salt (1:2)) AB08 (*Fosfatex) AC1NQXW7 AC1NS4CW AC1NUYS8 AC1O8PYM Alti-Doxycycline Anhydrous doxycycline Apo-Doxy Atridox Azudoxat BCBcMAP01_000024 BIDD:GT0146 BMY-28689 BPBio1_000951 BSPBio_000863 BSPBio_001936 BU-3839T C06973 CHEBI:50845 CHEMBL1433 CID5281011 CID5353597 CID5463943 CID6713981 CPD001550033 D07876 DB00254 DMSC (*Fosfatex) DOXCYCLINE ANHYDROUS DOXY DOXYCYCLINE CALCIUM DOXYCYCLINE MONOHYDRATE Deoxymykoin DivK1c_000345 Dossiciclina Dossiciclina [DCIT] Doxcycline anhydrous Doxiciclina Doxiciclina [INN-Spanish] Doxiciclina [Italian] Doxitard Doxivetin Doxy-Caps Doxy-Puren Doxy-Tabs Doxycen Doxychel Doxychel (TN) Doxycin Doxycyclin Doxycycline (200mg/day) or Placebo | Doxycycline (INN) Doxycycline (TN) Doxycycline (anhydrous) Doxycycline (internal use) Doxycycline Hyclate Doxycycline Monohydrate Doxycycline anhydrous Doxycycline hyclate Doxycycline-Chinoin Doxycyclinum Doxycyclinum [INN-Latin] Doxysol Doxytec Doxytetracycline EINECS 209-271-1 GS-3065 (*monohydrate) HMS2090E06 HSDB 3071 Hydramycin IDI1_000345 Investin Jenacyclin KBio1_000345 KBio2_001287 KBio2_003855 KBio2_006423 KBio3_001156 KBioGR_001133 KBioSS_001287 LS-187766 LS-93868 Liviatin Lopac0_000405 MolPort-002-507-423 Monodox Monodox (*monohydrate) NCGC00161602-01 NCGC00161602-03 NCGC00161602-04 NCGC00167961-01 NCGC00179395-01 NINDS_000345 NSC633557 Novo-Doxylin Nu-Doxycycline Oracea Prestwick0_000852 Prestwick1_000852 Prestwick2_000852 Prestwick3_000852 Ronaxan SAM002589932 SMP1_000107 SPBio_000246 SPBio_002784 STOCK1N-34341 Spanor Spectrum2_000143 Spectrum3_000408 Spectrum4_000527 Spectrum5_000947 Spectrum_000807 Supracyclin UNII-334895S862 UPCMLD-DP021 UPCMLD-DP021:001 Vibra-tabs Vibramycin Vibramycin (*monohydrate) Vibramycin Novum Vibramycine Vibravenos Vivox (*Hyclate) alpha-6-Deoxy-5-hydroxytetracycline alpha-6-Deoxyoxytetracycline alpha-Doxycycline doxycycline |
| | 37 | | Bevacizumab | approved, investigational | Phase 2, Phase 1 | 2020 | 216974-75-3 | | 216974-75-3 Avastin Avastin (TN) Bevacizumab Bevacizumab (genetical recombination) | Bevacizumab (genetical recombination) (JAN) D06409 R-435 anti-VEGF monoclonal antibody antiVEGF bevacizumab | |
| | 38 | | Letrozole | approved, investigational | Phase 2 | 397 | 112809-51-5 | 3902 | 1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole 1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole 112809-51-5 4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile) 4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole 4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile 4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile 4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile AB00514009 AC-1193 AC1L1GYT AKOS005145822 BIDD:GT0015 BIDD:PXR0130 BPBio1_001331 BRD-K88789588-001-03-2 BSPBio_001209 Bio-0057 C067431 C08163 C17H11N5 CAS-112809-51-5 CCRIS 8822 CGS 20267 CGS 20267, Femara, Piroxicam, Letrozole CGS-20267 CHEBI:6413 CHEMBL1444 CID3902 CPD000466343 | D00964 DB01006 FEM-345 Femara Femara (TN) Femera HMS1571M11 HMS2051E08 HMS2089L22 HSDB 7461 I06-0022 LS-38788 Letoval Letrozol Letrozole (JAN/USP/INN) Letrozole [USAN:INN] MLS000759455 MLS001424038 MLS002584991 MolPort-003-848-373 NCGC00016973-01 NCGC00016973-02 NSC719345 Novartis Brand of Letrozole Prestwick0_001025 Prestwick1_001025 Prestwick2_001025 Prestwick3_001025 S1235_Selleck SAM001246649 SMR000466343 SPBio_003070 TL8000371 UNII-7LKK855W8I ZINC03778874 letrozole |
| | 39 | | Trametinib | approved | Phase 2 | 131 | 871700-17-3 | 11707110 | GSK 1120212 GSK1120212 JTP 74057 JTP-74057 | MEK Inhibitor GSK1120212 Mekinist Trametinib Dimethyl Sulfoxide Trametinibum trametinib | |
| | 40 | | Fulvestrant | approved, investigational | Phase 2 | 202 | 129453-61-8 | 104741, 17756771 | (7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol (7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol 129453-61-8 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol 7alpha-(9-((4,4,5,5,5,-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol 7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol 7alpha-[9[(4,4,5,5,5-Pentafluropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17 beta diol AC-4693 AC1L2XEN AstraZeneca brand of fulvestrant BIDD:ER0348 BIDD:PXR0136 C070081 C32H47F5O3S CCRIS 8741 CHEBI:404798 CHEMBL1358 CID104741 D01161 DB00947 Faslodex Faslodex (TN) | Faslodex(ICI 182,780) Faslodex, ICI 182780, Fulvestrant Fulvestrant Fulvestrant (JAN/USAN/INN) Fulvestrant [USAN] HMS2090N22 HSDB 7658 I06-1109 ICI 182,780 ICI 182,789 ICI-182780 Ici 182780 LS-64781 NCGC00164789-02 NSC719276 S1191_Selleck UNII-22X328QOC4 ZD 182780 ZD-182780 ZD-9238 ZM 182780 ZM-182780 fulvestrant nchembio.168-comp5 nchembio.76-comp5 nchembio775-comp4 |
| | 41 | | Dasatinib | approved, investigational | Phase 2 | 285 | 302962-49-8 | 3062316 | (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide 1N1 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302962-49-8 AC1MI3ET AC1Q2P0C AmbotzLS-1203 Anhydrous dasatinib BCB03_000715 BMS 354825 BMS dasatinib BMS-354825 BMS-354825, Sprycel, BMS354825, Dasatinib BMS354825 C488369 CHEBI:49375 CHEMBL1421 CID3062316 D03658 DB01254 Dasatinib Dasatinib (USAN) Dasatinib (anh.) Dasatinib [USAN] Dasatinib anhydrous Dasatinib, BMS 354825 Dasatinibum EC-000.2122 | EN002710 FT-0084503 I14-1972 Kinome_3650 LS-186641 LS-187028 LS-187773 MolPort-003-846-143 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide NCGC00181129-01 NSC-732517 NSC732517 S1021_Selleck SPRYCEL (TN) Sprycel Spyrcel UNII-X78UG0A0RN anh. dasatinib dasatinib dasatinib (anhydrous) dasatinibum nchembio.117-comp11 nchembio.162-comp4 nchembio.332-comp1 | |
| | 42 | | Sunitinib | approved, investigational | Phase 2 | 510 | 341031-54-7, 557795-19-4 | 5329102 | (2S)-2-hydroxybutanedioic acid 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1) 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1) 326914-13-0 341031-54-7 5-(5-FLUORO-2-OXO-1,2-DIHYDRO-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLIC ACID (2-DIETHYLAMINO-ETHYL)-AMIDE 557795-19-4 AC1NS62J AC1O5CMQ AKOS005145765 Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1) CHEBI:38940 CHEBI:550864 CHEMBL1567 CHEMBL535 CID5329102 CID6456015 D06402 D08552 DB01268 DB07417 EN002687 FT-0083555 FT-0083556 I01-1229 K00588a KS-5022 LS-186078 LS-187023 LS-187648 MolPort-003-986-763 N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate N-(2-diethylaminoethyl)-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide NCGC00164631-01 | NSC736511 NSC750690 PDGF TK antagonist PHA-290940AD PNU-290940AD S1042_Selleck ST51053712 SU 011248 SU 11248 SU-010398 SU-011248 L-malate salt SU-11248 SU-11248 L-malate salt SU-11248J SU-12662 SU010398 SU011248 SU011248 L-malate salt SU11248 Su-011248 Sunitanib Sunitinib Sunitinib (INN) Sunitinib (free base) Sunitinib malate Sunitinib malate (JAN/USAN) Sunitinib malate [USAN] Sunitinibum Sutent Sutent (TN) Sutent, SU-11248 TL8002546 UNII-LVX8N1UT73 UNII-V99T50803M sunitinib sunitinibum | |
| | 43 | | Estradiol | approved, investigational, vet_approved | Phase 2 | 1318 | 50-28-2 | 5757, 53477783 | (+)-3,17b-Estradiol (17b)-Estra-1,3,5(10)-triene-3,17-diol (17beta)-Estra-1,3,5(10)-triene-3,17-diol .alpha.-Estradiol .alpha.-Oestradiol .beta.-Estradiol .beta.-Oestradiol 1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate 1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate 13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol 17 beta-Estradiol 17-.BETA.-Estradiol 17-E 17-beta 17-beta-OH-estradiol 17-beta-estradiol 17.beta.-Estradiol 17.beta.-Oestradiol 17E 17b-Estradiol 17b-Oestradiol 17beta Oestradiol 17beta oestradiol 17beta-Estra-1,3,5(10)-triene-3,17-diol 17beta-Estradiol 17beta-Oestradiol 1jgl 1qkt 1qku 2d06 3,17-Epidihydroxyestratriene 3,17-beta-Estradiol 3,17-beta-Oestradiol 3,17.beta.-Estradiol 3,17b-Dihydroxyestra-1,3,5(10)-triene 3,17b-Estradiol 3,17beta-Estradiol 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate 50-28-2 73459-61-7 873662-39-6 AC-10460 AC1L1L2K Aerodiol Agofollin Alora Altrad Amnestrogen Aquadiol B-Estradiol BEDOs BIDD:ER0125 BIDD:PXR0065 BPBio1_000532 BSPBio_000482 BSPBio_001065 Bardiol Benzhormovarine Beta-estradiol Bio-0812 Bio-E-Gel Bio1_000403 Bio1_000892 Bio1_001381 Bio2_000363 Bio2_000843 C00951 C18H24O2 CCRIS 280 CHEBI:16469 CHEMBL135 CID5757 CMC_11154 CPD-352 CPD000059126 Climaderm Climara Climara (TN) Climara Forte Compudose Compudose 200 Compudose 365 Corpagen D-3,17beta-Estradiol D-Estradiol D-Oestradiol D00105 DB00783 Dermestril Destradiol Dihydro-Theelin Dihydrofollicular hormone Dihydrofolliculin Dihydromenformon Dihydrotheelin Dihydroxyesterin Dihydroxyestrin Dihydroxyoestrin Dimenformon Diogyn Diogynets Divigel Divigel (TN) E 2 E 8875 E(sub 2) E0025 E1024_SIGMA E1132_SIGMA E2257_SIGMA E2758_SIGMA E8875_SIGMA EINECS 200-023-8 EU-0100503 Elestrin Encore Epiestriol 50 Esclim Estra-1,3,5(10)-triene-3,17b-diol Estrace Estrace (TN) Estraderm Estraderm (TN) Estraderm MX Estraderm TTS Estraderm TTS 100 Estraderm TTS 50 Estradiol Estradiol [USAN:INN] Estradiol-17 beta Estradiol-17-beta Estradiol-17.beta. Estradiol-17beta Estradiol-3,17beta Estradiolo Estradiolo [DCIT] Estradiolum Estradiolum [INN] Estradot Estraldine Estrapak 50 Estrasorb Estrasorb (TN) Estreva Estrifam Estring Estring (TN) Estring Vaginal Ring Estring vaginal ring Estroclim Estroclim 50 Estrodiolum Estrofem 2 Estrofem Forte Estrogel | Estrogel (TN) Estrogel HBF Estrovite Evamist Evorel Extrasorb Femanest Femestral Femestrol Femogen Fempatch Femtrace Femtran Follicyclin Gelestra Ginedisc Ginosedol GynPolar Gynergon Gynestrel Gynodiol Gynoestryl HMS1362E07 HMS1569I04 HMS1792E07 HMS1990E07 HMS2051C17 HMS2090E18 HSDB 3589 IDI1_002118 Innofem Innofem (TN) KBio2_000405 KBio2_002269 KBio2_002973 KBio2_004837 KBio2_005541 KBio2_007405 KBio3_000769 KBio3_000770 KBio3_002749 KBioGR_000405 KBioGR_002269 KBioSS_000405 KBioSS_002270 LMST02010001 LS-137 Lamdiol Lio-Oid Lopac0_000503 MLS000069494 MLS000758312 MLS001076331 Macrodiol Macrol Menest Menorest Menostar Microdiol MolPort-001-794-632 NCGC00091544-00 NCGC00091544-01 NCGC00091544-02 NCGC00091544-04 NCGC00091544-05 NCGC00091544-06 NCGC00091544-07 NCGC00091544-08 NCGC00091544-09 NCGC00091544-12 NCGC00179321-01 NCGC00179321-02 NSC-9895 NSC9895 Nordicol Oesclim Oestergon Oestra-1,3,5(10)-triene-3,17b-diol Oestradiol Oestradiol Berco Oestradiol R Oestradiol-17-beta Oestradiol-17.beta. Oestradiol-17beta Oestradiolum Oestrogel Oestroglandol Oestrogynal Ovahormon Ovasterol Ovastevol Ovociclina Ovocyclin Ovocycline Ovocylin Perlatanol Polyestradiol Prestwick0_000441 Prestwick1_000441 Prestwick2_000441 Prestwick3_000441 Prestwick_207 Primofol Profoliol Profoliol B Progynon Progynon DH Progynon-DH S-21400 S1709_Selleck SAM001247032 SK-Estrogens SL-1100 SMP1_000121 SMR000059126 SPBio_002421 Sandrena 1 Sandrena Gel Sisare Gel Spectrum5_002055 Syndiol Systen Tradelia Trial SAT Trocosone UNII-4TI98Z838E VIVELLE-DOT Vagifem Vagifem (TN) Vivelle Vivelle (TN) Zerella Zesteem Zesteen Zumenon [2,4,6,7-3H]-E2 [3H]-estradiol [3H]]estradiol b-Estradiol beta-Estradiol beta-Estradiol 3-sulfate beta-Estradiol 3-sulphate bmse000642 cMAP_000005 cis-Estradiol cis-Oestradiol component of Menrium delta-Estradiol delta-Oestradiol estradiol estradiol-17beta nchembio.168-comp3 nchembio.76-comp2 nchembio775-comp2 nchembio794-comp6 nchembio860-comp1 progynon | |
| | 44 | | Acetaminophen | approved | Phase 2 | 1026 | 103-90-2 | 1983 | 4'-Hydroxyacetanilide 4'-hydroxyacetanilide 4-(Acetylamino)phenol 4-Acetamidophenol 4-Acetaminophenol 4-Hydroxyacetanilide 4-Hydroxyanilid kyseliny octove 4-acetamidophenol A-Per A.F. Anacin AC1Q1KYJ AC1Q1KYK APAP Abenol Abensanil Abrol Abrolet Acamol Accu-Tap Acenol Acephen Acertol Aceta Elixir Aceta Tablets Acetaco Acetagesic Acetalgin Acetaminofen Acetaminophen Acetaminophen Uniserts Acetamol Acetavance Acetofen Actamin Actamin Extra Actamin Super Actifed Plus Actimol Actimol Chewable Tablets Actimol Children'S Suspension Actimol Infants' Suspension Actimol Junior Strength Caplets Actron Afebrin Afebryl Aferadol Algesidal Algina Algomol Algotropyl Allay Alpiny Alpinyl Alvedon Amadil Aminofen Aminofen Max Anacin Anacin 3 Anacin-3 Anacin-3 Extra Strength Anadin dla dzieci Anaflon Analter Anapap Andox Anelix Anexsia Anexsia 10/660 Anexsia 5/325 Anexsia 7.5/325 Anexsia 7.5/650 Anhiba Anoquan Anti-Algos Antidol Anuphen Apacet Apacet Capsules Apacet Elixir Apacet Extra Strength Caplets Apacet Extra Strength Tablets Apacet Regular Strength Tablets Apadon Apamid Apamide Apitrelal Apo-Acetaminophen Arfen Arthralgen Asetam Asomal Aspac Aspirin Free Anacin Maximum Strength Caplets Aspirin Free Anacin Maximum Strength Gel Caplets Aspirin Free Anacin Maximum Strength Tablets Aspirin-Free Anacin Aspirin-Free Excedrin Caplets Asplin Atasol Atasol Caplets Atasol Drops Atasol Forte Caplets Atasol Forte Tablets Atasol Oral Solution Atasol Tablets Atralidon Babikan Bacetamol Bancap Bancap Hc Banesin Bayer Select Bayer Select Allergy-Sinus Bayer Select Head Cold Bayer Select Headache Pain Bayer Select Maximum Strength Headache Pain Relief Formula Bayer Select Menstrual Multi-Symptom Bayer Select Sinus Pain Relief Ben-u-ron Benmyo Bickie-mol Biocetamol Bucet Butalbital Butapap CCRIS 3 CHEBI:46195 Cadafen Calapol Calmanticold Calonal Calpol Capital Capital with Codeine Captin Causalon Cefalex Cetadol Children'S Acetaminophen Elixir Drops Children'S Acetaminophen Oral Solution Children'S Tylenol Chewable Claradol Codeine Clixodyne Co-Gesic Cod-Acamol Forte Codabrol Codalgin Codapane Codicet Codisal Codisal Forte Codoliprane Codral Pain Relief Cofamol Conacetol Contac Cough & Sore Throat Formula Contra-Schmerz P Coricidin Coricidin D Coricidin Sinus Cosutone Croix Blanche Cuponol Curadon Curpol Custodial D oliprane Dafalgan Dapa Dapa X-S Darocet Darvocet Darvocet-N 50 Datril Datril Extra-Strength Daygrip Demilets Deminofen Democyl Demogripal Desfebre Dhamol Dhc Plus Dial-a-gesic Dial-alpha-gesic Dimindol Dirox Disprol Dol-Stop Dolcor Dolefin Dolegrippin Dolene AP-65 Dolene Ap-65 Dolgesic Doliprane Dolko Dolofugin Doloreduct Dolorfug Dolorol Forte Dolorstop Dolotec Dolprone Dorocoff Dresan Dristan Cold No Drowsiness Dristancito Drixoral Plus Duaneo Dularin Duorol Duracetamol Duradyne Dhc Durapan Dymadon Dymadon Co Dymadon Forte Dypap Ecosetol Elixodyne Empracet Endecon Enelfa Eneril Esgic Esgic-Plus Eu-Med Excedrin Excedrin Caplets Excedrin Extra Strength Caplets Excipain Exdol Exdol Strong Fanalgic Farmadol Febranine Febrectal Febrectol Febrex Febricet Febridol Febrilix Febrin Febrinol Febro-Gesic Febrolin Femcet Fendon Fensum Fepanil Fever All Feverall Feverall Junior Strength Feverall Sprinkle Caps Junior Strength Fevor Finimal Finiweh Fioricet Fluparmol Fortalidon P Freka-cetamol Gattaphen T Gelocatil Geluprane Genapap Genapap Children'S Elixir Genapap Children'S Tablets Genapap Extra Strength Caplets Genapap Extra Strength Tablets Genapap Regular Strength Tablets Genebs Genebs Extra Strength Caplets Genebs Regular Strength Tablets Genebs X-Tra Geralgine-P Gripin Bebe Grippostad Gynospasmine Hedex Helon N Homoolan Hy-Phen Hycomine Compound Hydrocet Ildamol Inalgex Infadrops Infants' Feverall Influbene N Injectapap Intensin Janupap Jin Gang Junior Disprol KBio1_000660 Kataprin Kinder Finimal Korum Kratofin simplex L024125 Labamol Lekadol Lemgrip Lemsip Lestemp Liqiprine Liquagesic Liquigesic Co Liquiprin Liquiprin Children'S Elixir Liquiprin Infants" Drops Lonarid Lonarid Mono Lorcet-Hd Lortab Lupocet Lyteca Lyteca Syrup Magnidol Malex N Malgis Malidens Maxadol Medigesic Plus Medinol Paediatric Medocodene Melabon Infantil Mexalen Midol Maximum Strength Midol PM Night Time Formula Midol Regular Strength Midol Teen Formula Migraleve Yellow Minafen Minoset Miralgin Momentum Mono Praecimed | Multin N-(4-Hydroxyphenyl)acetamide N-Acetyl-4-aminophenol N-Acetyl-p-aminophenol N-acetyl-p-aminophenol NAPA NCX 701 NEBS NSC3991 Naldegesic Napafen Napap Naprinol Nealgyl Nebs Neo-Fepramol NeoCitran Neodol Neodolito Neopap Neotrend Neuridon New Cortal for Children NilnOcen Nina No-Febril Nobedon Nodolex Noral Norcet Norco O-Acetaminophenol Ofirmev Oltyl Oralgan Oraphen-PD Ortensan Oxycet Oxycocet Oxycodone 2.5/Apap 500 Oxycodone 5/Apap 500 PCM Paracetamol Lichtenstein Paceco Pacemo Pacemol Pacet Pacimol Paedialgon Paedol Painex Paldesic Pamol Panacete Panadeine Panadeine Co Panadiene Panado-Co Panado-Co Caplets Panadol Panadol Extra Strength Panadol Junior Strength Caplets Panadol Maximum Strength Caplets Panadol Maximum Strength Tablets Panale ve Panaleve Panamax Panasorb Panasorbe Panets Panex Panodil Panofen Pantalgin Papa-Deine Papa-Deine #3 Papa-Deine #4 Para-Suppo Para-Tabs Paracemol Paracenol Paracet Paracetamol Paracetamol AL Paracetamol Antipanin P Paracetamol BC Paracetamol Basics Paracetamol DC Paracetamol Dr. Schmidgall Paracetamol Fecofar Paracetamol Genericon Paracetamol Hanseler Paracetamol Harkley Paracetamol Heumann Paracetamol Hexal Paracetamol Italfarmaco Paracetamol Nycomed Paracetamol PB Paracetamol Raffo Paracetamol Ratiopharm Paracetamol Rosch Paracetamol Saar Paracetamol SmithKline Beecham Paracetamol Stada Paracetamol Winthrop Paracetamol von ct Paracetamole Paracetamolo Paracetamolum Paracetanol Paracetol Paracin Paracod Paracodol Paracétamol Parador Paradrops Parakapton Parake Paralen Paralief Paralink Paralyoc Paramol Paramolan Paranox Parapan Parasedol Parasin Paraspen Parcetol Parelan Parmol Parogal Paroma Pasolind Pasolind N Pe-Tam Pediapirin Pediatrix Pedric Percocet Percocet-5 Percocet-Demi Percogesic with Codeine Perdolan Mono Perfalgan Phenaphen Phenaphen Caplets Phenaphen W/Codeine Phendon Phenipirin Phogoglandin Phrenilin Phrenilin Forte Pinex Piramin Pirinasol Plicet Polmofen Predimol Predualito Prestwick_13 Prodol Prompt Prontina Propacet Propacet 100 Proval #3 Puernol Pulmofen Pyregesic-C Pyrigesic Pyrinazine Pyromed Quiet World Redutemp Reliv Remedol Rhinex D-Lay Tablets Rivalgyl Robigesic Robitussin Night Relief Rockamol Plus Rounox Roxicet Roxicet 5/500 Roxilox RubieMol Rubophen Rupemol SK-Apap SPBio_002836 Salzone Sanicet Sanicopyrine Scanol Scentalgyl Scherzatabletten Rezeptur 534 Schmerzex Sedalito Sedapap Semolacin Servigesic Seskamol Setakop Setamol Setol Sifenol Sinaspril Sine-Off Sinus Medicine Caplets Sinedol Sinmol Sinubid Snaplets-FR Spalt N Spalt fur die nacht St Joseph Aspirin-Free St Joseph Aspirin-Free for Children St. Joseph Cold Tablets for Children St. Joseph Fever Reducer Stanback Stopain Sudafed Severe Cold Formula Sudafed Sinus Sunetheton Supac Supadol mono Supofen Suppap Suppap-120 Suppap-325 Suppap-650 Supramol-M Synalgos-Dc-A TYL Tabalgin Tachiprina Talacen Tapanol Tapanol Extra Strength Caplets Tapanol Extra Strength Tablets Tapar Tavist Allergy/Sinus/Headache Tazamol Temlo Tempanal Tempra Tempra Caplets Tempra Chewable Tablets Tempra D.S Tempra Drops Tempra Syrup Tencon Termacet Termalgin Termalgine Termofren TheraFlu Tibinide Tibizide Tiffy Tisin Tisiodrazida Titralgan Tizide Tocris-1706 Toximer P Tralgon Treupel N Treupel mon Treuphadol Triad Triaminic Sore Throat Formula Triaprin Tricoton Tussapap Ty lenol Tycolet Tylenol Tylenol (TN) Tylenol Allergy Sinus Tylenol Arthritis Extended Relief Tylenol Caplets Tylenol Children'S Chewable Tablets Tylenol Children'S Elixir Tylenol Children'S Suspension Liquid Tylenol Drops Tylenol Elixir Tylenol Extra Strength Adult Liquid Pain Reliever Tylenol Extra Strength Caplets Tylenol Extra Strength Gelcaps Tylenol Extra Strength Tablets Tylenol Gelcaps Tylenol Infants Drops Tylenol Infants" Suspension Drops Tylenol Junior Strength Caplets Tylenol Junior Strength Chewable Tablets Tylenol Regular Strength Caplets Tylenol Regular Strength Tablets Tylenol Tablets Tylex Tylex CD Tylol Tylox Tylox-325 Tymol Ultracet Upsanol Utragin Valadol Valgesic Valorin Valorin Extra Vanquish Veralgina Vermidon Verpol Viclor Richet Vicodin Vicodin Es Vicodin Hp Vips Viruflu Vivimed Volpan Wygesic Zatinol Zolben acetaminofén acétaminophène alpha-Per p-(Acetylamino)phenol p-Acetamidophenol p-Acetaminophenol p-Acetylaminophenol p-Hydroxyacetanilide p-Hydroxyphenolacetamide p-acetamidophenol p-acetaminophenol p-hydroxy-acetanilid p-hydroxyacetanilide p-hydroxyphenolacetamide |
| | 45 | | Maleic acid | experimental | Phase 2 | 296 | 110-16-7 | 444266 | (2Z)-2-Butenedioate (2Z)-2-Butenedioic acid (2Z)-Butene-2-dioate (2Z)-Butene-2-dioic acid (2Z)-but-2-enedioate (2Z)-but-2-enedioic acid (Z)-2-Butenedioate (Z)-2-Butenedioic acid (z)-butenedioate (z)-butenedioic acid 2-Butenedioate 2-Butenedioic acid Cis-butenedioate Cis-butenedioic acid | H2male Kyselina maleinova MAE Maleate Maleic acid Maleic acid [NA2215] Maleinic acid Malenic acid Malezid CM Scotchbond multipurpose etchant Toxilic acid cis-1,2-Ethylenedicarboxylic acid cis-2-Butenedioate cis-2-Butenedioic acid cis-But-2-enedioate cis-But-2-enedioic acid |
| | 46 | | Camptothecin | experimental | Phase 2 | 714 | 7689-03-4 | | (+)-camptothecin (+)-camptothecine (s)-(+)-camptothecin | (s)-camptothecin 20(S)-Camptothecin 21,22-Secocamptothecin-21-oic acid lactone Camptothecine D-camptothecin |
| | 47 | | Cediranib | investigational | Phase 2 | 93 | 288383-20-0 | 9933475 | 288383-20-0 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline 790713-41-6 AKOS005145767 AZD 2171 AZD-2171 AZD2171 AZD2171, Recentin, Cediranib CHEMBL491473 CID9933475 | Cediranib Cediranib (USAN/INN) Cediranib maleate D08881 EC-000.2328 Kinome_3318 M6294 NSC-732208 Recentin S1017_Selleck UNII-NQU9IPY4K9 ZD-2171 cediranib |
| | 48 | | Epothilone B | experimental, investigational | Phase 2 | 67 | 152044-54-7 | | | | 49 | | Protein Kinase Inhibitors | | Phase 2 | 3689 | | | | 50 | | Antibodies | | Phase 2, Phase 1 | 6394 | | |
Interventional clinical trials: (show top 50)
(show all 65)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer | Unknown status | NCT00954174 | Phase 3 | | 2 | Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus | Completed | NCT00002706 | Phase 3 | | 3 | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | Completed | NCT00006011 | Phase 3 | | 4 | Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer | Recruiting | NCT02065687 | Phase 2, Phase 3 | | 5 | Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol | Recruiting | NCT02501954 | Phase 3 | | 6 | Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | Active, not recruiting | NCT00063999 | Phase 3 | | 7 | Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer | Active, not recruiting | NCT00942357 | Phase 3 | | 8 | Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer | Active, not recruiting | NCT00807768 | Phase 3 | | 9 | Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer | Terminated | NCT00577317 | Phase 3 | | 10 | Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer | Unknown status | NCT02112552 | Phase 2 | | 11 | Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer | Completed | NCT00027690 | Phase 2 | | 12 | Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) | Completed | NCT00249990 | Phase 2 | | 13 | Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer | Completed | NCT01011933 | Phase 2 | | 14 | Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer | Completed | NCT00820898 | Phase 2 | | 15 | Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer | Completed | NCT00729586 | Phase 2 | | 16 | Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer | Completed | NCT01132820 | Phase 2 | | 17 | Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer | Completed | NCT01225887 | Phase 2 | | 18 | Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer | Completed | NCT01642082 | Phase 2 | | 19 | Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer | Completed | NCT01210222 | Phase 2 | | 20 | Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus | Completed | NCT00064025 | Phase 2 | | 21 | Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors | Completed | NCT00815945 | Phase 2 | | 22 | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer | Recruiting | NCT00492778 | Phase 2 | | 23 | Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | Recruiting | NCT01935934 | Phase 2 | | 24 | Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer | Recruiting | NCT01041027 | Phase 2 | | 25 | Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer | Recruiting | NCT02657928 | Phase 2 | | 26 | Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer | Recruiting | NCT02728258 | Phase 2 | | 27 | Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer | Recruiting | NCT02874430 | Phase 2 | | 28 | Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer | Active, not recruiting | NCT00006903 | Phase 2 | | 29 | Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | Active, not recruiting | NCT00478426 | Phase 2 | | 30 | Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer | Active, not recruiting | NCT01307631 | Phase 2 | | 31 | Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | Active, not recruiting | NCT00977574 | Phase 2 | | 32 | Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer | Active, not recruiting | NCT01935973 | Phase 2 | | 33 | Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer | Active, not recruiting | NCT00888173 | Phase 2 | | 34 | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer | Active, not recruiting | NCT01010126 | Phase 2 | | 35 | Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer | Active, not recruiting | NCT02059265 | Phase 2 | | 36 | Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer | Not yet recruiting | NCT03018249 | Phase 2 | | 37 | Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia | Terminated | NCT00503581 | Phase 2 | | 38 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | Completed | NCT00005840 | Phase 1 | | 39 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | Completed | NCT00005830 | Phase 1 | | 40 | Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRa-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer | Recruiting | NCT02996825 | Phase 1 | | 41 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers | Recruiting | NCT02020707 | Phase 1 | | 42 | TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors | Recruiting | NCT02142803 | Phase 1 | | 43 | Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer | Active, not recruiting | NCT00575952 | Phase 1 | | 44 | VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer | Not yet recruiting | NCT03120624 | Phase 1 | | 45 | Sentinel Node Biopsy in Endometrial Cancer | Unknown status | NCT01564264 | | | 46 | Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung | Completed | NCT00277082 | | | 47 | Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC) | Completed | NCT00250016 | | | 48 | Pre-Clinical Models in Gynecological Tumors A Tissue Repository | Completed | NCT00250783 | | | 49 | Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function | Completed | NCT01650987 | | | 50 | Collecting Tumor Samples From Patients With Gynecological Tumors | Completed | NCT00897442 | |
|
